Related Tags >> Xiaflex Pfizer Acorda Therapeutics BLA

Auxilium Pharmaceuticals News

Most Popular Auxilium Pharmaceuticals Story

On the Radar: Keep an eye on these biotech stocks

October 14, 2009 — 8:44am ET | By John Carroll

One developer is on the verge of a potential approval for a breakout new blockbuster, another has a therapy in closely-watched trials which could lay the foundation for a new drug capable of Read more...

Auxilium Pharmaceuticals Press Releases

Auxilium Pharmaceuticals to Announce Fourth Quarter 2011 Results and Conduct Conference Call on Thursday, February 23, 2012
EKR Therapeutics Names Two Independent Directors and Reaffirms Board of Directors to Lead Company Growth in the Critical C
Pharmaceutical Industry Leaders to Tackle Groundbreaking Challenges, Opportunities for Pharma & Biotech at Elite Event
Pfizer Inc. (PFE) Pays $7.5 Million Regulatory Milestone to Auxilium Pharmaceuticals (AUXL)
XIAFLEX for the Treatment of Dupuytren's Contracture Receives Priority Review From the U.S. Food and Drug Administration

Latest Headlines

Auxilium readies sales force on FDA Xiaflex approval
February 3, 2010
On the Radar: Keep an eye on these biotech stocks
October 14, 2009
FDA panel backs Auxilium's Xiaflex therapy
September 16, 2009
Auxilium's xiaflex BLA granted priority review
April 29, 2009
Auxilium scores $485M pact with Pfizer
December 18, 2008
Press Release: Auxilium Pharmaceuticals Temporarily Suspends Dosing in Phase III Trials for AA4500
December 6, 2006
The best (and worst) biotech stocks of 2006
December 1, 2006
ALSO NOTED: Acorda gains $10M in funds; Supreme Court debates patent law; and much more...
November 28, 2006
Press Release: Auxilium Pharmaceuticals Amends Agreement with Cobra Biologics
November 28, 2006
ALSO NOTED: Santarus inks licensing deal; NeurogesX reports positive data; and much more...
October 17, 2006
ALSO NOTED: Neose restructures, sells facility; Warner Chilcott announces IPO terms; and much more...
September 4, 2006
ALSO NOTED: Auxilium enrolling patients; Wyeth wins conditional approval; and much more...
June 28, 2006
ALSO NOTED: Schering terminates NexMed deal; Rubin resigns from Critical Therapeutics; and much more...
June 25, 2006
ALSO NOTED: Takeda to collaborate with Santhera; Isotechnika touts trial results; Orchid Chemicals raising $100M; and much more
August 2, 2005
ALSO NOTED: HGS pockets milestone money; CollaGenex files NDA; Large Scale Biology wins orphan drug status; and much more...
July 31, 2005
ALSO NOTED: Critical Therapeutics shares surge; Orchid gets FDA OK; MedImmune pulls flyer; and much more...
June 28, 2005

Paid Research Reports

More Research Reports >>

Free Newsletter

Most Popular Stories

Webinars

Hottest Products

Featured Jobs

Events